Synokem Pharama gets CDSCO panel nod to manufacture, market Naftifine HCL Cream 2% Dr. Divya Colin22 Dec 2022 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceutical has got green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
IPCA Labs, Cadila Healthcare among 16 Indian pharma firms blacklisted in Nepal Ruchika Sharma21 Dec 2022 3:24 PM ISTKathmandu: In a major setback, Nepal has banned import of medicines from 16 Indian pharmaceutical companies including IPCA Laboratories,...
NPPA Fixes Retail Price Of 10 Formulations, Details Susmita Roy20 Dec 2022 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Conduct CT in Indian population: CDSCO Panel Tells AstraZeneca for Anifrolumab Dr. Divya Colin19 Dec 2022 6:00 PM ISTNew Delhi: Highlighting that the there is no study data available in Indian population for monoclonal antibody Anifrolumab 150mg/ml concentrate for...
Novo Nordisk gets CDSCO Panel nod to study NN0365-3769 Dr. Divya Colin18 Dec 2022 5:00 PM ISTNew Delhi: In a significant development, the drug major Novo-Nordisk has got approval from the Subject Expert Committee (SEC) functional under the...
Novartis gets CDSCO panel nod to study anticancer drug JDQ443 Dr. Divya Colin17 Dec 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Novartis, has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
DCGI calls out WHO for 'prematurely' blaming Maiden Pharma for cough syrup linked deaths in Gambia Farhat Nasim16 Dec 2022 6:04 PM IST"It is clear that perhaps premature deduction was drawn on September 29th itself regarding the cause of death. Every subsequent alert or publication...
Submit Phase IV CT protocol: CDSCO Panel tells Roche over Anti-Cancer drug Pralsetinib Dr. Divya Colin16 Dec 2022 6:00 PM ISTNew Delhi: Reiterating the earlier recommendation regarding the condition of conduct a Phase IV clinical trial of anti-neoplastic drug Pralsetinib,...
CDSCO opines J&J to submit details of Anticancer Drug Teclistamab approval in EU, US Dr. Divya Colin15 Dec 2022 6:00 PM ISTNew Delhi: In response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and...
83 Drug Samples Fail To Qualify CDSCO Test Susmita Roy14 Dec 2022 6:00 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 83 medicine...
Submit in vitro data and comparative data: CDSCO Tells Dr Reddy's on Icosapent Ethyl Capsule Dr. Divya Colin13 Dec 2022 6:00 PM ISTNew Delhi: Noting that the effect of Icosapentether on the risk of pancreatitis in patients with severe hypertriglyceridemia has yet to be determined,...
Glenmark gets CDSCO Panel nod to Study FDC Of Bilastine, Dextromethorphan ,Phenylephrine Syrup Dr. Divya Colin12 Dec 2022 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to drug...
